A new way for SGD investors to tap the biggest stocks in China’s A-share market

FSMOne.com
FSMOne.com27 Mar 2025 3708 Views
A new way for SGD investors to tap the biggest stocks in China’s A-share market

What is the FTSE China A50 Index?

The FTSE China A50 Index (the “Index”) is one of the most recognised China A-share indices. Launched over 20 years ago, it comprises China’s 50 largest A-share companies listed on the Shanghai or Shenzhen stock exchanges. These 50 stocks represent about one third of the entire A share market by weight.

Why China A shares?

The A share market is popular among investors seeking exposure to China’s domestic growth potential. A-share companies typically serve the domestic market and as such, generate the bulk of their revenue from Chinese consumers. This makes them relatively better positioned to weather ongoing US-China trade tensions, and are better placed to benefit from China’s stimulus plans.

Eight benefits of the UOBAM FTSE China A50 Index ETF (“the Fund”)

#1. Exposure to big name stocks

The Fund offers investors access to some of the most well-established stocks in the China A-share market. These include well-known names such as liquor giant Kweichow Moutai, battery maker Contemporary Amperex Technology (CATL), and the Industrial & Commercial Bank of China (ICBC).

These companies reflect some of most important themes within China’s modern economy, including decarbonization, financial services and domestic consumption.

Source: Bloomberg, as of 28 Feb 2025

#2. Potential to outperform in market rallies

China’s large cap stocks have outperformed their smaller cap peers during recent market rallies. This is because popular indices and ETFs that benefit the most from foreign investor flows, tend to feature large cap stocks. As a result, in 2024, when the China market rallied on the back of stimulus measures, large cap indices like the FTSE China A50 Index outperformed all cap indices such as the FTSE China A All Cap.

Source: FTSE, Index performance relative to the FTSE China A All Cap Index (in CNY). Data as of 29 November 2024, based on three years of historical data

#3. Potential resilience in down markets

Large cap stocks also tend to be more stable given the companies’ strong brand presence and significant market share, especially during times of economic uncertainty. This is because investors are more inclined to hold on to such stocks for their dividend payments and good fundamentals, despite downward market pressures.

Source: FTSE, Index performance relative to the FTSE China A All Cap Index (in CNY). Data as of 29 November 2024, based on three years of historical data


#4. Denominated in SGD

The Fund is listed on the Singapore Exchange (SGX) and offers trading in SGD. This is particularly appealing for Singapore investors who do not want to bother with currency exchange issues. The majority of China-focused ETFs are listed in Hong Kong or the US, and offered in HKD or USD, which is inconvenient for investors whose wealth and portfolios are SGD-based. Singaporeans can also buy into the Fund using their SRS funds. There are no Customer Account Review (CAR) requirements as the Fund is an Excluded Investment Product (EIP).

#5. Diversification across key industries

China’s economy has transformed significantly over the past 20 years and the FTSE China A50 Index has evolved alongside. The country’s focus on innovation and consumption-led growth have increased the weighting of consumer, technology and healthcare companies within the Index. Such companies now make up 39 percent of the Index, three times more than in 2015. In contrast, financials, which made up more than 60 percent of the Index a decade ago, now occupies just a third of the index. By investing in the Fund rather than individual stocks, investors ensure that they are in lockstep with the changing face of China’s economy.

#6. Regular dividend payments

Another benefit of the Index’s large cap exposure is the potential for attractive income. Large cap companies tend to have more room to pay dividends compared to growth-focused smaller caps. The average dividend yield for the FTSE China A50 index is 3.6 percent compared to the all-caps average dividend yield of 2.4 percent. The Fund aims to provide annual distributions1, making it an appealing choice for income-seeking investors.

#7. Low cost and transparent

The Fund offers ongoing exposure to China’s biggest stocks via a single vehicle, based on a quarterly rebalancing cycle. This means that if a stock shrinks in size and is no longer a Top 50 stock, it will be automatically replaced without investors needing to keep track. Additionally, to prevent excessive turnover, there is a buffer zone in place around the 50th ranked stock.

#8. No minimum board lot size

The Fund, as a Singapore-listed ETF, can be bought from just one unit, in contrast to most Hong Kong listed ETFs, which usually require a minimum lot size of 100 units. This makes it easy for investors to tactically allocate to the ETF as part of a well-diversified portfolio.

Distributions are not guaranteed. Distributions may be made out of income, capital gains and/or capital. This relates to the disclosed distribution policy as set out in the Fund's prospectus.

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.